In a proposed pharmaceutical class proceeding alleging that anti-psychotic medications caused gynecomastia and that the defendants failed to warn of that risk, the moving defendants sought pre-certification production of broad medical and pharmacy records for five affiants.
The court held that pre-certification medical production must be limited to records bearing on certification issues and rejected any request that effectively sought entire medical files.
It confirmed production of records relating to prescriptions, ingestion, development of gynecomastia, related risk or warning discussions, and related surgeries.
The court refused on the present record to compel further diagnosis and treatment records aimed at individual causation or vague assertions about commonality and preferability, but left the issue open for renewal on cross-examination.